Search research articles
Contact Us
Filters
Showing results (31-40 of 97) with videos related to
Page
of 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2006
Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination
Nelson DiPaolo, Shaoheng Ni, Anuj Gaggar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
Darren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Scientific Reports
|
September 21, 2017
Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma
Jacqueline Estevez, Vincent L Chen, Ondrej Podlaha, et al.
Scientific Reports
|
September 13, 2017
Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers
Vincent L Chen, An K Le, Ondrej Podlaha, et al.
Journal of Viral Hepatitis
|
December 13, 2019
Liver safety assessment in clinical trials of new agents for chronic hepatitis B
Robert J Fontana, Mark I Avigan, Harry L A Janssen, et al.
The Lancet. Microbe
|
September 17, 2020
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study
Catherine A Chappell, Kimberly K Scarsi, Brian J Kirby, et al.
Hepatology International
|
May 6, 2016
Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India
Aracely Tamayo, Samir R Shah, Shobna Bhatia, et al.
Gastroenterology
|
January 7, 2022
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao-Chun Hsu, Vithika Suri, Mindie H Nguyen, et al.
Hepatology Communications
|
January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2019
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
Maria Buti, David K Wong, Edward Gane, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 97) with videos related to
Sort By:
Page
of 10
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2006
Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination
Nelson DiPaolo, Shaoheng Ni, Anuj Gaggar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
Darren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Scientific Reports
|
September 21, 2017
Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma
Jacqueline Estevez, Vincent L Chen, Ondrej Podlaha, et al.
Scientific Reports
|
September 13, 2017
Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers
Vincent L Chen, An K Le, Ondrej Podlaha, et al.
Journal of Viral Hepatitis
|
December 13, 2019
Liver safety assessment in clinical trials of new agents for chronic hepatitis B
Robert J Fontana, Mark I Avigan, Harry L A Janssen, et al.
The Lancet. Microbe
|
September 17, 2020
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study
Catherine A Chappell, Kimberly K Scarsi, Brian J Kirby, et al.
Hepatology International
|
May 6, 2016
Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India
Aracely Tamayo, Samir R Shah, Shobna Bhatia, et al.
Gastroenterology
|
January 7, 2022
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao-Chun Hsu, Vithika Suri, Mindie H Nguyen, et al.
Hepatology Communications
|
January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2019
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
Maria Buti, David K Wong, Edward Gane, et al.
Page
of 10